abstract |
The present invention relates to a solid form of a compound of formula (I), a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and the use of the solid form in the treatment of Janus kinase (JAK)-associated diseases, including, for example, inflammatory diseases, autoimmune diseases and cancers. |